Hydrocortisone modulates cholera toxin endocytosis by regulating immature enterocyte plasma membrane phospholipids

Lei Lu1, Yuanwu Bao, Abdullah Khan

  • 1Developmental Gastroenterology Laboratory, Massachusetts General Hospital for Children, Boston, Massachusetts, USA. lul@helix.mgh.harvard.edu

Gastroenterology
|May 6, 2008
PubMed

Insights

Neonates are susceptible to diarrhea due to immature enterocytes. This study reveals that developmental changes in cholera toxin (CT) endocytosis are linked to increased GM1-lipid raft association in developing intestinal cells.

Area of Science:

  • Gastroenterology
  • Cell Biology
  • Pediatric Infectious Diseases

Background:

  • Diarrheal diseases pose a significant global health burden, particularly in infants and children.
  • Immature enterocytes in neonates may contribute to increased susceptibility to diarrhea caused by bacterial toxins.

Purpose of the Study:

  • To investigate developmental differences in cholera toxin (CT)-GM1-mediated endocytosis in human intestinal cells.

Main Methods:

  • Utilized fetal and mature human intestinal epithelial cell lines (H4, T84), primary cells, and xenografts.
  • Employed hydrocortisone to induce enterocyte maturation.
  • Analyzed CT-GM1 endocytosis pathways using electron microscopy and lipid raft association studies.

Main Results:

  • Observed increased CT-caveolae and decreased CT-clathrin colocalization in mature versus immature enterocytes.
  • Found significant GM1 partitioning into lipid rafts in mature cells, which was enhanced by hydrocortisone.
  • Demonstrated that maturational changes in phospholipid composition, including increased phosphatidylcholine and sphingomyelin, correlate with enhanced CT-GM1/lipid raft association.

Conclusions:

  • Developmental changes in CT endocytosis are partly attributed to increased GM1-lipid raft association.
  • Maturation of enterocyte phospholipid composition plays a crucial role in regulating CT endocytosis.
Abstract

Related Concept Videos

Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...